MRC1 and ovarian carcinoma: In vitro studies have found an association between MMR deficiency and resistance to platinum agents and DNA methylating agents such as 6-thioguanine, due to an inactivation of MMR driven apoptosis in ovarian cancer cell lines [77, 78].